Danielle Campfield-Carter will celebrate two years cancer free, but her journey to remission has been anything but easy.

As temperatures rose in more than a dozen Middle Eastern and North African countries over the past two decades, cancer ...

Scientists found that climate change in the Middle East and North Africa is making breast, ovarian, uterine, and cervical ...

Short-term testosterone use among transmasculine and gender diverse (TMGD) individuals is not associated with an increased risk for gynecological cancers.

Under the terms of the clinical trial collaboration and supply agreement, Coherus will provide LOQTORZI to STORM, which will be the sponsor of the Phase 1b/2 clinical combination trial. STORM and ...

Contrast-enhanced mammography identified three times as many tumors as ultrasound scans. But it is not widely used for ...

Genmab has shared the first data on rinatabart sesutecan (Rina-S) in advanced endome | Genmab has shared the first data on ...

PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that the ...

Tumors with high levels of microsatellite instability (MSI-H), such as some subsets of colorectal, endometrial and gastric cancers, are associated with a hypermutated phenotype and a specific ...

Scientists created a new nanoparticle aimed at making ultrasound-based cancer therapy more safe and effective.

Leveraging Northway Biotech’s 20+ years of CDMO expertise, Kaida BioPharma is advancing KAD101, a targeted therapy for ...